Patients with early-stage MS had significant subpial demyelination at autopsy.
Leptomeningeal lymphoid-like structures (LLS) were previously noted to be prevalent in progressive multiple sclerosis (MS), correlating with disease severity (NEJM JW Neurol Nov 2011 and Brain 2011; 134:2755). Imaging studies suggested the presence of LLS in early MS, little pathologic material has been available. Investigators have now studied autopsy material from 12 patients with acute MS, with median disease duration 2 y (range, 0.3–4 years) and median age at death 35 years (range, 22–58). Also studied were autopsy samples from 3 patients with primary progressive MS and 18 with secondary progressive MS.
The percent of cortical gray matter with demyelination was 11.9% in acute MS and 29.1% in progressive MS. The percent of white matter de…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)